Karuna Therapeutics

YTD

ALL

Why Robinhood?

You can watch KRTX and buy or sell other stocks, ETFs, and their options commission-free!

About KRTX

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.

CEO

William J. Meury

CEOWilliam J. Meury

Employees

—

Employees—

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2009

Founded2009

Employees

—

Employees—

KRTX Key Statistics

Market cap

12.60B

Market cap12.60B

Price-Earnings ratio

-28.13

Price-Earnings ratio-28.13

Dividend yield

—

Dividend yield—

Average volume

525.45K

Average volume525.45K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$329.99

52 Week high$329.99

52 Week low

$158.38

52 Week low$158.38

People also own

Based on the portfolios of people who own KRTX. This list is generated using Robinhood data, and it’s not a recommendation.